The following groups are recommended to receive hepatitis B vaccine because of their increased risk of infection through blood products:15

  • people with clotting disorders who receive blood product concentrates
  • people with recurrent transfusion requirements
  • people with underlying immunocompromising conditions who receive blood products 

All blood donors in Australia are screened for hepatitis B using tests for hepatitis B surface antigen and nucleic acid amplification. This has greatly decreased the incidence of transfusion-related hepatitis B virus infection. 

Adult-formulation hepatitis B vaccine should be given in a 3-dose schedule. See Table. Monovalent hepatitis B vaccines for adolescents and adults in Vaccines, dosage and administration.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018